Benitec Biopharma Inc (BNTC)
6.90
-0.04
(-0.58%)
USD |
NASDAQ |
Apr 26, 16:00
6.95
+0.05
(+0.72%)
After-Hours: 20:00
Benitec Biopharma Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2021 | 50.00% |
March 31, 2021 | -600.0% |
December 31, 2020 | |
September 30, 2020 | -143.6% |
June 30, 2020 | |
March 31, 2020 | -67.86% |
December 31, 2019 | |
September 30, 2019 | 21.21% |
June 30, 2018 | |
March 31, 2018 | -58.28% |
December 31, 2017 | 53.01% |
Date | Value |
---|---|
September 30, 2017 | 73.02% |
June 30, 2017 | 83.30% |
March 31, 2017 | 23.34% |
December 31, 2016 | 30.44% |
September 30, 2016 | 80.18% |
June 30, 2016 | 16.19% |
March 31, 2016 | 58.90% |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | 99.98% |
March 31, 2015 | 92.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-600.0%
Minimum
Mar 2021
50.00%
Maximum
Jun 2021
-148.1%
Average
-67.86%
Median
Mar 2020
Gross Profit Margin (Quarterly) Benchmarks
Galectin Therapeutics Inc | -- |
TG Therapeutics Inc | 82.14% |
BioVie Inc | -- |
Jaguar Health Inc | 70.13% |
First Wave BioPharma Inc | -- |